PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

117 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
41.
Nückel, J.* et al.: Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity. Front. Immunol. 13:889836 (2022)
42.
Ren, L.* et al.: Applications and immunological effects of quantum dots on respiratory system. Front. Immunol. 12:795232 (2022)
43.
Sun, Z.J.* et al.: Construction of a lactate-related prognostic signature for predicting prognosis, tumor microenvironment, and immune response in kidney renal clear cell carcinoma. Front. Immunol. 13:818984 (2022)
44.
Walker, A.* et al.: Immune escape pathways from the HBV core18-27 CD8 T cell response are driven by individual HLA class I alleles. Front. Immunol. 13:1045498 (2022)
45.
Xiong, K.* ; Qi, M.* ; Stöger, T. ; Zhang, J.* & Chen, S.*: The role of tumor-associated macrophages and soluble mediators in pulmonary metastatic melanoma. Front. Immunol. 13:1000927 (2022)
46.
Zauhar, R.* et al.: As in real estate, location matters: Cellular expression of complement varies between macular and peripheral regions of the retina and supporting Tissues. Front. Immunol. 13:895519 (2022)
47.
Blank, S. & Hilger, C.*: Editorial: Novel advances in allergy diagnosis and treatment. Front. Immunol. 12:662699 (2021)
48.
Brand, I.* et al.: Broad T cell targeting of structural proteins after SARS-CoV-2 infection: High throughput assessment of T cell reactivity using an automated interferon gamma release assay. Front. Immunol. 12:688436 (2021)
49.
Chu, C.F.* et al.: Convalescent COVID-19 patients without comorbidities display similar immunophenotypes over time despite divergent disease severities. Front. Immunol. 12:601080 (2021)
50.
Cirac, A.* et al.: Immunoinformatic analysis reveals antigenic heterogeneity of Epstein-Barr virus is immune-driven. Front. Immunol. 12:796379 (2021)
51.
Grunewald, C.M.* et al.: Epigenetic priming of bladder cancer cells with decitabine increases cytotoxicity of human EGFR and CD44v6 CAR engineered T-cells. Front. Immunol. 12:782448 (2021)
52.
Holmen Olofsson, G.* et al.: Vγ9Vδ2 T cells concurrently kill cancer cells and cross-present tumor antigens. Front. Immunol. 12:645131 (2021)
53.
Hose, A.J.* et al.: Excessive unbalanced meat consumption in the first year of life increases asthma risk in the PASTURE and LUKAS2 birth cohorts. Front. Immunol. 12:651709 (2021)
54.
Klopp, A. et al.: Depletion of T cells via inducible caspase 9 increases safety of adoptive T-cell therapy against chronic hepatitis B. Front. Immunol. 12:734246 (2021)
55.
Körber, N. et al.: Hepatitis B vaccine non-responders show higher frequencies of CD24highCD38high regulatory B cells and lower levels of IL-10 expression compared to responders. Front. Immunol. 12:713351 (2021)
56.
Linder, A.* et al.: Defective interfering genomes and the full-length viral genome trigger RIG-I after infection with vesicular stomatitis virus in a replication dependent manner. Front. Immunol. 12:595390 (2021)
57.
Mishto, M.* ; Mansurkhodzhaev, A.* ; Rodriguez-Calvo, T. & Liepe, J.*: Potential mimicry of viral and pancreatic β cell antigens through non-spliced and cis-spliced zwitter epitope candidates in type 1 diabetes. Front. Immunol. 12:656451 (2021)
58.
Olguín-Contreras, L.F. ; Mendler, A.N. ; Popowicz, G.M. ; Hu, B. & Nößner, E.: Double strike approach for tumor attack: Engineering T cells using a CD40L:CD28 chimeric co-stimulatory switch protein for enhanced tumor targeting in adoptive cell therapy. Front. Immunol. 12:750478 (2021)
59.
Rodriguez-Calvo, T. ; Johnson, J.D.* ; Overbergh, L.* & Dunne, J.L.*: Neoepitopes in type 1 diabetes: Etiological insights, biomarkers and therapeutic targets. Front. Immunol. 12:667989 (2021)
60.
Rodriguez-Calvo, T. et al.: Means, motive, and opportunity: Do non-islet-reactive infiltrating T cells contribute to autoimmunity in type 1 diabetes? Front. Immunol. 12:683091 (2021)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... ▶▶ ▶▮